Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03044028 · ClinicalTrials.gov registry record · NA

Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)

A NA study of Arthropathy of Knee Joint, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT03044028: Completed NA study of Arthropathy of Knee Joint, sponsored by The Cleveland Clinic.

NCT03044028 is a NA study of Arthropathy of Knee Joint that has completed, run by The Cleveland Clinic. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03044028, a NA study of Arthropathy of Knee Joint, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The current standard for rehabilitation after TKA consists of guided exercise therapy for up to 12 weeks after surgery. This includes inpatient, home, and outpatient therapy. The surgery and rehabilitation are highly successful at reducing or eliminating pain experienced preoperatively. However, quadriceps femoris muscle (QFM) strength, overall function, and knee range of motion are often worse than preoperative levels for as long as 6 months after surgery and in some cases may persist for many years after that. Such quadriceps strength impairments after TKA have been largely attributed to voluntary activation deficits and can lead to a decrease in functional performance such as decreased gait speed, decreased balance which can lead to falls, and decreased stair climbing \& chair rise abilities. Since therapy alone does not adequately restore or improve upon the preoperative functional capabilities in a consistent and timely manner, it has been suggested that NMES used adjunctively with postoperative rehabilitation will alleviate the quadriceps muscle activation deficits. Early NMES use after TKA has been shown to: reduce knee extensor lag, increase walking speed, and improve QFM strength, knee range of motion, and function. However, NMES initiated one month after TKA did not lead to improved QFM strength or function beyond the standard benefits gained from exercise alone, thus suggesting that the timing of NMES application after TKA is important. It has previously been shown that preoperative QFM strength is predictive of postoperative function \[6\] but the benefit of prehabilitation remains in question. To date, there has only been one pilot study assessing the benefits of NMES when initiated preoperatively. This study only included 14 patients (9 NMES, 5 control) but was able to show that preoperative NMES usage may lead to greater QFM strength gains after TKA. Therefore, it will be important to assess the benefits of NMES both preoperatively and postoperative

Primary Outcome

measure change in muscle strength (QFM) - difference from baseline measure to 6 weeks postoperative

Conditions Studied

Interventions

  • DEVICE CyMedica Orthopedics QB1 e-vive™ system

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2017-01
Est. Completion 2018-08
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT03044028 record still lists

NCT03044028 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Arthropathy of Knee Joint appearing as the primary indexed condition, and to 1 intervention - of which CyMedica Orthopedics QB1 e-vive™ system is the first listed.

NCT03044028 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT03044028 about?

NCT03044028 is a clinical study titled "Neuromuscular Electrical Stimulation (NMES) for Improving Outcomes Following Total Knee Arthroplasty (TKA)". The current standard for rehabilitation after TKA consists of guided exercise therapy for up to 12 weeks after surgery. This includes inpatient, home, and outpatient therapy. The surgery and rehabilitation are highly successful at reducing or eliminating pain experienced preoperatively. However, qua...

What is the current status of trial NCT03044028?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2017-01. Estimated completion is 2018-08.

What conditions does trial NCT03044028 study?

This clinical trial studies the following conditions: Arthropathy of Knee Joint.

What interventions are being tested in trial NCT03044028?

The interventions under investigation include: CyMedica Orthopedics QB1 e-vive™ system (DEVICE).

Who is sponsoring clinical trial NCT03044028?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03044028 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthropathy of Knee Joint

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03044028's enrollment target sits among peer trials

66 1139th of 2000 higher than 857 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03044028, the US trial registry maintained by the National Library of Medicine. NCT03044028 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.